Clinical Trials Browser

Phase 3 × Doxorubicin × Tumor-Agnostic × Clear all

NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Phase 3 Unknown

Neoplasms, Unknown Primary